Literature DB >> 21549338

A missense mutation in PRPF6 causes impairment of pre-mRNA splicing and autosomal-dominant retinitis pigmentosa.

Goranka Tanackovic1, Adriana Ransijn, Carmen Ayuso, Shyana Harper, Eliot L Berson, Carlo Rivolta.   

Abstract

Retinitis pigmentosa (RP) is an inherited form of retinal degeneration that leads to progressive visual-field constriction and blindness. Although the disease manifests only in the retina, mutations in ubiquitously expressed genes associated with the tri-snRNP complex of the spliceosome have been identified in patients with dominantly inherited RP. We screened for mutations in PRPF6 (NM_012469.3), a gene on chromosome 20q13.33 encoding an essential protein for tri-snRNP assembly and stability, in 188 unrelated patients with autosomal-dominant RP and identified a missense mutation, c.2185C>T (p.Arg729Trp). This change affected a residue that is conserved from humans to yeast and cosegregated with the disease in the family in which it was identified. Lymphoblasts derived from patients with this mutation showed abnormal localization of endogenous PRPF6 within the nucleus. Specifically, this protein accumulated in the Cajal bodies, indicating a possible impairment in the tri-snRNP assembly or recycling. Expression of GFP-tagged PRPF6 in HeLa cells showed that this phenomenon depended exclusively on the mutated form of the protein. Furthermore, analysis of endogenous transcripts in cells from patients revealed intron retention for pre-mRNA bearing specific splicing signals, according to the same pattern displayed by lymphoblasts with mutations in other PRPF genes. Our results identify PRPF6 as the sixth gene involved in pre-mRNA splicing and dominant RP, corroborating the hypothesis that deficiencies in the spliceosome play an important role in the molecular pathology of this disease.
Copyright © 2011 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21549338      PMCID: PMC3146730          DOI: 10.1016/j.ajhg.2011.04.008

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  31 in total

Review 1.  Retinitis pigmentosa and allied diseases: numerous diseases, genes, and inheritance patterns.

Authors:  Carlo Rivolta; Dror Sharon; Margaret M DeAngelis; Thaddeus P Dryja
Journal:  Hum Mol Genet       Date:  2002-05-15       Impact factor: 6.150

2.  Mutations in a protein target of the Pim-1 kinase associated with the RP9 form of autosomal dominant retinitis pigmentosa.

Authors:  T Jeffrey Keen; Matthew M Hims; Arthur B McKie; Anthony T Moore; Rob M Doran; David A Mackey; David C Mansfield; Robert F Mueller; Shomi S Bhattacharya; Alan C Bird; Alexander F Markham; Chris F Inglehearn
Journal:  Eur J Hum Genet       Date:  2002-04       Impact factor: 4.246

3.  Mutations in the pre-mRNA splicing factor gene PRPC8 in autosomal dominant retinitis pigmentosa (RP13).

Authors:  A B McKie; J C McHale; T J Keen; E E Tarttelin; R Goliath; J J van Lith-Verhoeven; J Greenberg; R S Ramesar; C B Hoyng; F P Cremers; D A Mackey; S S Bhattacharya; A C Bird; A F Markham; C F Inglehearn
Journal:  Hum Mol Genet       Date:  2001-07-15       Impact factor: 6.150

Review 4.  Retinitis pigmentosa. The Friedenwald Lecture.

Authors:  E L Berson
Journal:  Invest Ophthalmol Vis Sci       Date:  1993-04       Impact factor: 4.799

5.  A human homolog of yeast pre-mRNA splicing gene, PRP31, underlies autosomal dominant retinitis pigmentosa on chromosome 19q13.4 (RP11).

Authors:  E N Vithana; L Abu-Safieh; M J Allen; A Carey; M Papaioannou; C Chakarova; M Al-Maghtheh; N D Ebenezer; C Willis; A T Moore; A C Bird; D M Hunt; S S Bhattacharya
Journal:  Mol Cell       Date:  2001-08       Impact factor: 17.970

6.  RNAi knockdown of hPrp31 leads to an accumulation of U4/U6 di-snRNPs in Cajal bodies.

Authors:  Nina Schaffert; Markus Hossbach; Rainer Heintzmann; Tilmann Achsel; Reinhard Lührmann
Journal:  EMBO J       Date:  2004-07-15       Impact factor: 11.598

7.  A role for Cajal bodies in the final steps of U2 snRNP biogenesis.

Authors:  Dobrila Nesic; Goranka Tanackovic; Angela Krämer
Journal:  J Cell Sci       Date:  2004-08-17       Impact factor: 5.285

8.  PAP-1, the mutated gene underlying the RP9 form of dominant retinitis pigmentosa, is a splicing factor.

Authors:  Hiroshi Maita; Hirotake Kitaura; T Jeffrey Keen; Chris F Inglehearn; Hiroyoshi Ariga; Sanae M M Iguchi-Ariga
Journal:  Exp Cell Res       Date:  2004-11-01       Impact factor: 3.905

9.  A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa.

Authors:  E L Berson; B Rosner; M A Sandberg; K C Hayes; B W Nicholson; C Weigel-DiFranco; W Willett
Journal:  Arch Ophthalmol       Date:  1993-06

10.  Targeting of U4/U6 small nuclear RNP assembly factor SART3/p110 to Cajal bodies.

Authors:  David Stanĕk; Stephen D Rader; Mirko Klingauf; Karla M Neugebauer
Journal:  J Cell Biol       Date:  2003-02-10       Impact factor: 10.539

View more
  52 in total

1.  Haploinsufficiency of a spliceosomal GTPase encoded by EFTUD2 causes mandibulofacial dysostosis with microcephaly.

Authors:  Matthew A Lines; Lijia Huang; Jeremy Schwartzentruber; Stuart L Douglas; Danielle C Lynch; Chandree Beaulieu; Maria Leine Guion-Almeida; Roseli Maria Zechi-Ceide; Blanca Gener; Gabriele Gillessen-Kaesbach; Caroline Nava; Geneviève Baujat; Denise Horn; Usha Kini; Almuth Caliebe; Yasemin Alanay; Gulen Eda Utine; Dorit Lev; Jürgen Kohlhase; Arthur W Grix; Dietmar R Lohmann; Ute Hehr; Detlef Böhm; Jacek Majewski; Dennis E Bulman; Dagmar Wieczorek; Kym M Boycott
Journal:  Am J Hum Genet       Date:  2012-02-02       Impact factor: 11.025

2.  Long-term clinical course of 2 Japanese patients with PRPF31-related retinitis pigmentosa.

Authors:  Kentaro Kurata; Katsuhiro Hosono; Yoshihiro Hotta
Journal:  Jpn J Ophthalmol       Date:  2018-01-05       Impact factor: 2.447

3.  Unraveling the mysteries of pre-mRNA splicing in the retina via stem cell technology.

Authors:  Rob W J Collin
Journal:  Stem Cell Investig       Date:  2016-11-04

Review 4.  Evolutionary conservation and expression of human RNA-binding proteins and their role in human genetic disease.

Authors:  Stefanie Gerstberger; Markus Hafner; Manuel Ascano; Thomas Tuschl
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

5.  RNA Splicing Factor Mutations That Cause Retinitis Pigmentosa Result in Circadian Dysregulation.

Authors:  Iryna Shakhmantsir; Scott J Dooley; Siddharth Kishore; Dechun Chen; Eric Pierce; Jean Bennett; Amita Sehgal
Journal:  J Biol Rhythms       Date:  2019-11-15       Impact factor: 3.182

6.  EFTUD2 deficiency in vertebrates: Identification of a novel human mutation and generation of a zebrafish model.

Authors:  Brett Deml; Linda M Reis; Sanaa Muheisen; David Bick; Elena V Semina
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2015-06-27

7.  Haploinsufficiency of SF3B4, a component of the pre-mRNA spliceosomal complex, causes Nager syndrome.

Authors:  Francois P Bernier; Oana Caluseriu; Sarah Ng; Jeremy Schwartzentruber; Kati J Buckingham; A Micheil Innes; Ethylin Wang Jabs; Jeffrey W Innis; Jane L Schuette; Jerome L Gorski; Peter H Byers; Gregor Andelfinger; Victoria Siu; Julie Lauzon; Bridget A Fernandez; Margaret McMillin; Richard H Scott; Hilary Racher; Jacek Majewski; Deborah A Nickerson; Jay Shendure; Michael J Bamshad; Jillian S Parboosingh
Journal:  Am J Hum Genet       Date:  2012-04-26       Impact factor: 11.025

Review 8.  Genetic characterization and disease mechanism of retinitis pigmentosa; current scenario.

Authors:  Muhammad Umar Ali; Muhammad Saif Ur Rahman; Jiang Cao; Ping Xi Yuan
Journal:  3 Biotech       Date:  2017-07-18       Impact factor: 2.406

Review 9.  RNA mis-splicing in disease.

Authors:  Marina M Scotti; Maurice S Swanson
Journal:  Nat Rev Genet       Date:  2015-11-23       Impact factor: 53.242

Review 10.  Alternative splicing and retinal degeneration.

Authors:  M M Liu; D J Zack
Journal:  Clin Genet       Date:  2013-06-05       Impact factor: 4.438

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.